Differential mortality by measles vaccine titer and sex.
about
Use of licensed vaccines for active immunization of the immunocompromised hostUse of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virusSafety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and LessonsComparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in miceFully immunized child: coverage, timing and sequencing of routine immunization in an urban poor settlement in Nairobi, Kenya.Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4.A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measlesHuman parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines.Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trialTesting the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countriesCombination vaccines: defining and addressing current safety concerns.Gender differences in the perception of asthma and respiratory symptoms in a population sample of asthma patients in four Brazilian citiesVaccination against measles: a neverending story.Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infantsDifferential immune responses to primary measles-mumps-rubella vaccination in Israeli children.The facial evolution: looking backward and moving forward.Reflections of a Vaccinologist: Lessons Learned About What We Can Do to Improve Trust in Vaccines and Vaccine Programsa.The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.Sex-differential and non-specific effects of routine vaccinations in a rural area with low vaccination coverage: an observational study from Senegal.Sex-differential effects on mortality of BCG and diphtheria-tetanus-pertussis vaccines in a rural area with high vaccination coverage: observational study from Senegal.Measles Vaccine.Percentile regression analysis of correlated antibody responses
P2860
Q24533456-43F82B42-CBEB-4587-9268-145A4F0FBCD4Q24658311-70C6C7C2-1362-44EE-B0BA-8BFD6CAF89C7Q26778259-C7F9D00A-6C6A-4F46-9BCC-D8D9DEB27CD9Q28752489-673DCA40-9AB3-4C57-9A00-52236CB7B0DFQ30382785-8665E4E1-9F7B-4600-BF85-5D290D5313C1Q33723524-653A38A3-1533-4545-AF66-BF2A146DFE1CQ33769306-9C3773C6-4260-4E53-A805-8B6DA38A5607Q33808578-F7FE4F67-9491-4817-AE79-E1BC66FFB941Q33920185-90393F5B-BE48-45A2-8D26-7B5B846A4ABEQ33945271-A9B9FD1F-5619-441E-A79E-41F5735826CFQ33998162-A7344CB2-3163-4492-BB0F-D0AA318FC25CQ34152512-1235C89F-6997-4BAC-9A13-918389BD9E2CQ34276739-628EA72B-C6B1-4FD2-AFF6-1A87D5BE468AQ34440127-DCAC6C65-5CE4-4558-8FF0-DC6EC51EF790Q34993081-7F8C536E-BAE4-416B-AA47-B0E372D3A6EEQ35193416-3EF272BB-AA47-4C3B-8DF7-03B05D9AB692Q36539048-EBF10E84-BC79-454A-B2E0-843CE89CB6BCQ36606717-873E7D18-816E-49E4-A243-1C7D1BE785BCQ36904712-67F8000A-194A-4FC5-86B6-BDC5934B0F09Q37069798-87B66A51-0AE5-42C7-8609-E128A4F2B608Q37075237-7D11AF95-7A70-401D-AFB7-8682C7A88148Q37495055-85405AB9-F6C7-4AA6-A115-CF1F88AFAA58Q38049128-AB36494D-F278-4FBE-823F-21DCE7B8B438Q38649736-D8ED0EB7-DEF8-4401-862F-90D0889B0D94Q39688587-274E9716-9AF7-49EB-AA41-BF657FA08CD5Q41602677-4D8F7DC1-90F7-4329-82B4-95C046BCB430Q46187222-18234741-51C1-49D1-8880-2343C8061584Q46300761-6C59ED88-4267-4E03-9A1D-0263E12B1212Q57954270-CFC7E009-3F06-40D5-91A4-58F1D05F5CA0
P2860
Differential mortality by measles vaccine titer and sex.
description
1993 nî lūn-bûn
@nan
1993 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Differential mortality by measles vaccine titer and sex.
@ast
Differential mortality by measles vaccine titer and sex.
@en
Differential mortality by measles vaccine titer and sex.
@nl
type
label
Differential mortality by measles vaccine titer and sex.
@ast
Differential mortality by measles vaccine titer and sex.
@en
Differential mortality by measles vaccine titer and sex.
@nl
prefLabel
Differential mortality by measles vaccine titer and sex.
@ast
Differential mortality by measles vaccine titer and sex.
@en
Differential mortality by measles vaccine titer and sex.
@nl
P2093
P356
P1476
Differential mortality by measles vaccine titer and sex.
@en
P2093
P304
P356
10.1093/INFDIS/168.5.1087
P407
P577
1993-11-01T00:00:00Z